Cargando…
AXL as a Target in Breast Cancer Therapy
AXL is a receptor tyrosine kinase (RTK) that has been implicated in diverse tumor-promoting processes such as proliferation, migration, invasion, survival, and apoptosis. AXL therefore plays a role in cancer progression, and AXL has been implicated in a wide variety of malignancies from solid tumors...
Autor principal: | Colavito, Sierra A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7042526/ https://www.ncbi.nlm.nih.gov/pubmed/32148495 http://dx.doi.org/10.1155/2020/5291952 |
Ejemplares similares
-
AXL kinase as a novel target for cancer therapy
por: Wu, Xiaoliang, et al.
Publicado: (2014) -
Giving AXL the axe: targeting AXL in human malignancy
por: Gay, Carl M, et al.
Publicado: (2017) -
Targeting AXL in NSCLC
por: Zaman, Aubhishek, et al.
Publicado: (2021) -
AXL in cancer: a modulator of drug resistance and therapeutic target
por: Tang, Yaoxiang, et al.
Publicado: (2023) -
AXL Receptor in Breast Cancer: Molecular Involvement and Therapeutic Limitations
por: Falcone, Italia, et al.
Publicado: (2020)